JP Patent

JP7689979B2 — 抗体薬物複合体を含む医薬組成物及びその使用

Assigned to Shanghai Hengrui Pharmaceutical Co Ltd · Expires 2025-06-09 · 1y expired

What this patent protects

Patent listed against edoxaban-tosylate.

Drugs covered by this patent

Patent Metadata

Patent number
JP7689979B2
Jurisdiction
JP
Classification
Expires
2025-06-09
Drug substance claim
No
Drug product claim
No
Assignee
Shanghai Hengrui Pharmaceutical Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.